BURLINGAME, Calif., May 22 /PRNewswire/ -- BioSeek, Inc., a leader in applying integrated human biology systems for developing new therapeutics, announced today the signing of a joint research collaboration agreement with Amylin Pharmaceuticals, Inc. that will focus on the discovery and development of novel peptide therapeutics for inflammatory conditions. Amylin has also made a $10 million equity investment in BioSeek.
